Skip to main content
SpringerLink
Log in

Caprine mucopolysaccharidosis IIID

Fetal and neonatal brain and liver glycosaminoglycan and morphological perturbations

  • Original Article
  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Mucopolysaccharidosis IIID (MPS IIID) is a lysosomal storage disease associated with deficient activity of the enzyme N-acetylglucosamine 6-sulfatase (EC 3.1.6.14), a lysosomal hydrolase in the heparan sulfate glycosaminoglycan (HS-GAG) degradation pathway. In caprine MPS IIID, enzyme replacement therapy reversed early postnatal systemic but not primary or secondary central nervous system (CNS) substrate accumulations. The caprine MPS IIID large animal model system was used in this investigation to define the developmental profile of morphological and biochemical perturbations to estimate a time frame for therapeutic intervention. Light and electron microscopy were used to compare the CNS, liver, and kidney of normal +/+, MPS IIID carrier +/-, and MPS IIID-affected -/- goat kids (kids), at 60, 113–114, 128–129, and 135 d gestation (dg) of a 150-d gestational period, at birth, and at 59–64 d of postnatal (d-pn) age. In the CNS of -/- kids, morphological correlations of HS-GAG and glycolipid accumulations were evident in early differentiating neurons at 60 dg. CNS and systemic developmental, regional, and cellular differences in -/-kids at all time points included more prominent and earlier accumulation of lucent, putative HS-GAG substrates in lysosomes of meningeal and perivascular macrophages and hepatic sinusoidal cells than in CNS, hepatic, or renal parenchymal cells. The amounts and compositions of HS-GAG substrates in the brain and liver of +/+, +/-, and -/- kids were determined at 60, 65, 113–114, and 128–135 dg, at birth, and 53–78 d-pn. In the CNS of -/- kids, HS-GAG concentrations were variable and exceeded those of age-matched control tissue samples in the third but not the second trimester. In contrast, hepatic HS-GAG levels in -/- kids exceeded control values at all time points evaluated and paralleled the progressive morphological alterations. CNS and hepatic HS-GAG compositions in -/- kids were similar to each other and were more complex at all pre- and postnatal ages than those from control kids. Based on the time frame of development of CNS lesions and biochemical perturbations, prenatal therapeutic intervention in caprine MPS IIID is likely to be necessary to prevent or ameliorate substantive CNS and systemic lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Ando S. (1983) Gangliosides in the nervous system. Neurochem. Int. 5, 507–537.

    Article  CAS  PubMed  Google Scholar 

  • Auclair D., Hopwood J. J., Brooks D. A., Lemontt J. A., and Crawley A. C. (2003) Replacement therapy in mucopolysaccharidosis type VI: advantages of early onset of therapy. Mol. Genet. Metab. 78, 163–174.

    Article  PubMed  CAS  Google Scholar 

  • Avila J. L. and Convit J. (1975) Inhibition of leucocytic lysosomal enzymes by glycosaminoglycans in vitro Biochem. J. 152, 57–64.

    PubMed  CAS  Google Scholar 

  • Baumkotter J. and Cantz M. (1983) Decreased ganglioside neuraminidase activity in fibroblasts from mucopolysaccharidosis patients. Inibition of the activity in vitro by sulfated glycosaminoglycans and other compounds. Biochim. Biophys. Acta 761, 163–170.

    PubMed  CAS  Google Scholar 

  • Blumenkrantz N. and Asboe-Hansen G. (1973) New method for quantitative determination of uronic acid. Anal. Biochem. 54, 484–489.

    Article  PubMed  CAS  Google Scholar 

  • Byers S., Rolazkis T., Brumfield L. K., Ranieri E., and Hopwood, J. J. (1998). Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS. Mol. Gene Met. 65, 282–290.

    Article  CAS  Google Scholar 

  • Casal M. L. and Wolfe J. H. (2000) Mucopolysaccharidosis type VII in the developing mouse fetus. Pediatr. Res. 47, 750–756.

    Article  PubMed  CAS  Google Scholar 

  • Castagnaro M., Alroy J., Ucci A. A., and Glew R. H. (1987) Lectin histochemistry and ultrastructure of feline kidneys from six different storage diseases. Virchows Arch. B. 54, 16–26.

    PubMed  CAS  Google Scholar 

  • Cavanagh K. T., Leipprandt J. R., Jones M. Z., and Friderici K. (1995) Molecular defect of caprine N-acetylglucosamine-6-sulphatase deficiency. A single base substitution creates a stop codon in the 5′-region of the coding sequence. J. Inherit. Metab. Dis. 18, 96.

    Article  PubMed  CAS  Google Scholar 

  • Ceuterick C., Martin J. J., Libert J., and Farriaux J. P (1980) Sanfilippo A disease in the fetus-comparison with pre- and postnatal cases. Neuropadiatrie 11(2), 176–185.

    Article  PubMed  CAS  Google Scholar 

  • Downs-Kelly E., Jones M. Z., Alroy J., Cavanagh K. T., King B., Lucas R. E., et al. (2000) Caprine mucopolysaccharidosis IIID: A preliminary trial of enzyme replacement therapy. J. Mol. Neurosci. 15, 251–262.

    Article  PubMed  CAS  Google Scholar 

  • Friderici K., Cavanagh K. T., Leipprandt J. R., Traviss C. E., Anson D. S., Hopwood J. J., and Jones M. Z. (1995) Cloning and sequence analysis of caprine N-acetylglucosamine 6-sulfatase cDNA. Biochim. Biophys. Acta 1271, 369–373.

    PubMed  Google Scholar 

  • Fu H., Samulski R. J., McCown T. J., Picornell Y. J., Fletcher D., and Muenzer J. (2002) Neurological correction of lysosomal storage in a mucopolysaccharidosis IIIB mouse model by adeno-associated virus-mediated gene delivery. Mol. Ther. 5, 42–49.

    Article  PubMed  CAS  Google Scholar 

  • Ginsberg S. D., Galvin J. E., Lee V. M. Y., Rorke L. B., Dickson D. W., Wolfe J. H., et al. (1999) Accumulation of intracellular amyloid-β peptides (Aβ1-40) in mucopolysaccharidosis brains. J. Neuropathol. Exp. Neurol. 58, 815–824.

    PubMed  CAS  Google Scholar 

  • Gliddon B. L. and Hopwood J. J. (2004) Enzyme replacement therapy from birth delays the development of behavior and learning problems in mucopolysaccharidosis type-IIIA mice. Pediatr. Res. 56, 65–72.

    Article  PubMed  CAS  Google Scholar 

  • Greenwood R. S., Hillman R. E., Alcala H., and Sly W. S. (1978) Sanfilippo A syndrome in the fetus. Clin. Genet. 13, 241–250.

    Article  PubMed  CAS  Google Scholar 

  • Hannun Y. A. and Bell R. M. (1987) Lysosphingolipids inhibit protein kinase C: implications for the sphingolipidoses. Science 235, 670–674.

    Article  PubMed  CAS  Google Scholar 

  • Harper P. S., Laurence K. M., Parkes A., Wusteman F. S., Kresse H., von Figura K., et al. (1974) Sanfilippo A disease in the fetus. J. Med. Genet. 11, 123–132.

    PubMed  CAS  Google Scholar 

  • Haskins M. E., Otis E. J., Hayden J. E., Jezyk P. F., and Stramm L. (1992) Hepatic storage of glycosaminoglycans in feline and canine models of mucopolysaccharidosis I, VI, and VII. Vet. Pathol. 29, 112–119.

    Article  PubMed  CAS  Google Scholar 

  • Ho T. T., Maguire A. M. Aguirre G. D., Surace E. M., Anand V., Zeng Y., et al. (2002) Phenotypic rescue after adenoassociate virus-mediated delivery of 4-sulfatase to the retinal pigment epithelium of feline mucopolysaccharidosis VI. J. Genet. Med. 4, 613–621.

    CAS  Google Scholar 

  • Ikeno T., Minami R., Tsugawa S., and Nakao T. (1982) Acidic glycosaminoglycans and gangliosides in the brains from four patients with genetic mucopolysaccharidosis. Tohoku J. Exp. Med. 137, 253–260.

    PubMed  CAS  Google Scholar 

  • Instani M., Irie F., Plump A. S., Tessier-Lavigne M., and Yamaguchi Y. (2003) Mammalian brain morphogenesis and midline axon guidance require heparan sulfate. Science 302, 1044–1046.

    Article  CAS  Google Scholar 

  • Jones M. Z., Alroy J., Boyer P. J., Cavanagh K. T., Johnson K., Gage D., et al. (1998) Caprine mucopolysaccharidosis-IIID: clinical, biochemical, morphological and immunohistochemical characteristics. J. Neuropathol. Exp. Neurol. 57, 148–157.

    PubMed  CAS  Google Scholar 

  • Jones M. Z., Alroy J., Rutledge J. C., Taylor J. W., Alvord E. C., Jr., Toone J., et al. (1997) Human mucopolysaccharidosis IIID: clinical, biochemical, morphological and immunohistochemical characteristics. J. Neuropathol. Exp. Neurol. 56, 1158–1167.

    Article  PubMed  CAS  Google Scholar 

  • Jones M. Z., Rathke E. J. S., Cavanagh K., and Hancock L. W. (1984) β-Mannosidosis: Prenatal biochemical and morphological characteristics. J. Inher. Metab. Dis. 7, 80–85.

    Article  PubMed  CAS  Google Scholar 

  • Leipprandt J. R., Friderici K., Sprecher D. J., and Jones M. Z. (1995) Prenatal testing for caprine N-acetylglucosamine-6-sulphatase deficiency and sex identification. J. Inher. Metab. Dis. 18, 647–648.

    Article  PubMed  CAS  Google Scholar 

  • Liour S. S., Jones M. Z., Suzuki M., Bieberich E., and Yu, R. K. (2001) Metabolic studies of glycosphingolipid accumulation in mucopolysaccharidosis IIID. Mol. Genet. Metab. 72, 239–247.

    Article  PubMed  CAS  Google Scholar 

  • Lovell K. L., Kraemer S. A., Leipprandt J. R., Sprecher D. J., Ames N. K., Nichols-Torrez J., et al. (2001) In utero hematopoietic stem cell transplantation: a caprine model for prenatal therapy in inherited metabolic diseases. Fetal Diagn. Ther. 16, 13–17.

    Article  PubMed  CAS  Google Scholar 

  • Lovell K. L., Matsuura F., Patterson J., Baeverfjord G., Ames N. K., and Jones M. Z. (1997) Biochemical and morphological expression of early prenatal caprine β-mannosidosis. Prenat. Diagn. 1, 551–557.

    Article  Google Scholar 

  • Lovell K. L., Mitchell-Herpolsheimer C., Ames N. K., and Snyder E. Y. (1996) Prenatal engraftment of CNS stem-like cells: an approach to therapy for caprine β-mannosidosis. Soc. Neurosci. Abstr. 22, 577–577.

    Google Scholar 

  • Meier C., Wiesmann U., Herschkowitiz N., and Bischoff A. (1979) Morphological observations in the nervous system of prenatal mucopolysaccharidosis II (M. Hunter) Acta Neuropathol. 48, 139–143.

    Article  PubMed  CAS  Google Scholar 

  • Meertens L., Zhao Y., Rosic-Kablar S., Li L., Chan K., Dobson H., et al. (2002) In utero injection of α-L-iduronidase-carrying retrovirus in canine mucopolysaccharidosis type I: infection of multiple tissues and neonatal gene expression. Hum. Gene Ther. 13, 1809–1820.

    Article  PubMed  CAS  Google Scholar 

  • Mito T., Nakano C. Yoshino K., Takashima S., Hashimoto K., Yumoto T., and Tanaka J. (1984) Histopathological study on the fetus of Sanfilippo B Disease. No To Hattatsu 16, 481–486.

    PubMed  CAS  Google Scholar 

  • Neufeld E. F. and Muenzer J. (2001) The mucopolysaccharidoses in The Metabolic and Molecular Bases of Inherited Disease, Scriver, C. R., Beaudet, A. L., Sly, W. S., Valle, D., Childs B., Kinzler K. W., and Vogelstein B., eds., McGraw-Hill, New York, pp. 3421–3452.

    Google Scholar 

  • Obeid L. M., Linardic C. M., Karolak L. A., and Hannun Y. A. (1993) Programmed cell death induced by ceramide. Science 259, 1769–1771.

    Article  PubMed  CAS  Google Scholar 

  • Ogawa-Goto K., Funamoto N., Abe T., and Nagashima K. (1990) Different ceramide compositions of gangliosides between human motor and sensory nerves. J. Neurochem. 55, 1486–1493.

    Article  PubMed  CAS  Google Scholar 

  • Perrimon N. and Bernfield M. (2000) Specificities of heparan sulphate proteoglycans in developmental processes. Nature 404, 725–728.

    Article  PubMed  CAS  Google Scholar 

  • Prasad A., Kaye E. M., and Alroy J. (1996) Electron microscopic examination of skin biopsy as a cost-effective tool in the diagnosis of lysosomal storage diseases. J. Child. Neurol. 11, 301–308.

    PubMed  CAS  Google Scholar 

  • Salmivirta M., Lidholt K., and Lindahl U. (1996) Heparan sulfate: a piece of information. FASEB J. 10, 1270–1279.

    PubMed  CAS  Google Scholar 

  • Sands M. S., Vogler C., Kyle J. W., Grubb J. H., Levy B., Galvin N., Sly W. S., and Birkenheimer G. H. (1994) Enzyme replacement therapy for murine mucopolysaccharidosis type VII. J. Clin. Invest. 93, 2324–2331.

    PubMed  CAS  Google Scholar 

  • Selleck S. B. (2000) Proteoglycans and pattern formation: sugar biochemistry meets developmental genetics. Trends Genet. 16, 206–212.

    Article  PubMed  CAS  Google Scholar 

  • Selznick L. A., Zheng T. S., Flavell R. A., Rakic P., and Roth K. A. (2000) Amyloid beta-induced neuronal death is bax-dependent but caspase-independent. J. Neuropathol. Exp. Neurol. 59, 271–279.

    PubMed  CAS  Google Scholar 

  • Thompson J. N., Jones M. Z., Dawson G., and Huffman P. S. (1992) N-acetylglucosamine 6-sulphatase deficiency in a Nubian goat: a model of Sanfilippo syndrome type D (mucopolysaccharidosis IIID). J. Inher. Metab. Dis. 15, 760–768.

    Article  PubMed  CAS  Google Scholar 

  • Tumova S., Woods A., and Couchman J. R. (2000) Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int. J. Biochem. Cell. Biol. 32, 269–288.

    Article  PubMed  CAS  Google Scholar 

  • Vogler C., Levy B., Galvin N. J., Thorpe C., Sands M. S., Barker J. E., et al. (1999) Enzyme replacement in murine mucopolysaccharidosis type VII: neuronal and glial response to beta-glucuronidase requires early initiation of enzyme replacement therapy. Pediatr. Res. 45, 838–844.

    Article  PubMed  CAS  Google Scholar 

  • Wiesmann U., Spycher M. A., Meier C., Liebaers I. L., and Herschkowitz N. (1980) Prenatal mucopolysaccharidosis II (Hunter): a pathogenetic study. Pediatr. Res. 14, 749–756.

    Article  PubMed  CAS  Google Scholar 

  • Yu R. K. and Saito M. (1989) Structure and localization of gangliosides, in Neurobiology of Glycoconjugates, Margolis, R. U., and Margolis, R. K., eds., Plenum Press, New York, pp. 1–42.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Human Pathology, Colleges of Human and Osteopathic Medicine, Michigan State University, 48824, East Lansing, MI

    Margaret Z. Jones, Erinn Downs-Kelly & Rebecca E. Lucas

  2. Department of Pathology, Schools of Medicine and Veterinary Medicine, Tufts University, 02111, Boston, MA

    Joseph Alroy

  3. Institute of Molecular Medicine and Genetics, Medical College of Georgia, 30912, Augusta, GA

    Stacey A. Kraemer

  4. Michigan Department Community Health, Bureau of Laboratories, 48909, Lansing, MI

    Kevin T. Cavanagh

  5. Lysosomal Storage Diseases Unit, Department of Chemical Pathology, Women’s and Children’s Hospital, North Adelaide, South Australia

    Barbara King & John J. Hopwood

Authors
  1. Margaret Z. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph Alroy
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Erinn Downs-Kelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rebecca E. Lucas
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stacey A. Kraemer
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kevin T. Cavanagh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Barbara King
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. John J. Hopwood
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Margaret Z. Jones.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jones, M.Z., Alroy, J., Downs-Kelly, E. et al. Caprine mucopolysaccharidosis IIID. J Mol Neurosci 24, 277–291 (2004). https://doi.org/10.1385/JMN:24:2:277

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1385/JMN:24:2:277

Index Entries

Search

Navigation